We have previously reported that the expression of
matrix metalloproteinase-9 (MMP-9), membrane type-1
matrix metalloproteinase (MT1-MMP) and beta1
integrins in murine
hepatocellular carcinoma (HCC) was associated with the occurrence of intrahepatic
metastasis, which is considered to be a major modality in recurrence. Here we show that
intravenous administration of synthetic RGD pseudo-
peptide (FC-336) inhibited intrahepatic
metastasis produced by orthotopic implantation of a fragment of murine HCC (CBO140C12)
tumor as compared with control administration of vehicle (p<0.05), but did not affect the growth of the implanted
tumor. To further analyze the anti-metastatic effect of
FC-336, we investigated the effects of
FC-336 on
tumor growth, adhesion and invasion in vitro.
FC-336 at non-cytotoxic concentration of less than 5 mg/ml effectively inhibited the adhesion and invasion of CBO140C12 cells (p<0.05). We also used zymography to examine the effect of
FC-336 on the gelatinolysis of
MMPs produced by CBO140C12 cells.
FC-336 inhibited the degradation of the
gelatin substrate by MMP-9 in a concentration-dependent manner. These results strongly suggest that intrahepatic
metastasis of CBO140C12
tumors is partly due to the marked invasive and adhesive abilities of
tumor cells mediated by expression of MMP-9 and
integrin alpha3beta1 (VLA-3),
integrin alpha5beta1 (VLA-5) on the
tumor surface, respectively.